Global Drug and Gene Delivery Systems Market Size, and Forecast 2017-2025 | Oxford BioMedica, Pfizer, Amgen Inc., Astrazeneca plc, Bayer AG, SiBiono GeneTech Co.

ResearchMoz presents professional and in-depth study of "Drug and Gene Delivery Systems Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017-2025"

Drug delivery includes formulations, technologies, methods, and systems used for transferring an active pharmaceutical ingredient into the body as desired, in order to safely accomplish its therapeutic effect. Gene delivery is a procedure employed to introduce foreign DNA into host cells. Rising prevalence of chronic diseases such as cancer and diabetes is increasing the demand for drug and gene delivery systems. According to JAMA Oncology, around 17.5 million new cancer cases were reported across the world in 2015. According to a WHO report published in 2017, around 1.0 million people died of HIV infection across the globe in 2016. Several advancements have been made in the field of drug and gene delivery systems such as nanoparticle technology, Prodrug formulation, liposomes & hydrogels, particle engineering & particulate systems, and three-dimensional printing (3DP) in order to attain sustained and controlled release of drugs.

Click to get Sample PDF @ https://www.researchmoz.us/enquiry.php?type=S&repid=1707720

Drug and Gene Delivery Systems Market: Segmentation

The drug and gene delivery systems market has been segmented in terms of delivery system, route of administration, application, and geography. Based on delivery system, the market has been segmented into drug delivery systems and gene delivery systems. The drug delivery systems segment has been sub-segmented into intrauterine implants, Prodrug implants, polymeric drug delivery, and targeted drug delivery. The gene delivery systems segment has been sub-segmented into viral gene delivery, non-viral gene delivery, and combined hybrid system. The viral gene delivery sub-segment has been further classified into adenovirus vector, lentivirus vector, retrovirus vector, adeno-associated virus vector, Sendai virus vector, herpes simplex virus vector, and others. The non-viral gene delivery sub-segment has been further classified into natural organic compounds, physical methods, and chemical methods. Based on route of administration, the market has been segmented into oral, injectable, inhalation, transdermal, ocular, nasal, and topical. In terms of application, the market has been divided into infectious diseases, oncology, ophthalmology, urology, diabetes, CNS, and others. Based on geography, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The research is a combination of primary and secondary research, which has been conducted for understanding and arriving at trends and used to forecast the revenue expected to be generated in the global drug and gene delivery systems market in the near future. Primary research represents a bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key market experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentations, and various international and national databases. The report provides estimated market size (in US$ Bn) of segments based on delivery system, route of administration, application, and geography for the period from 2015 to 2025, considering the macro and micro environmental factors. The revenue generated by each of these segments was calculated by considering the drug and gene delivery system market product sales.

The report comprises an elaborate executive summary which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to segments based on delivery system, route of route of administration, application, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that influence the drug and gene delivery systems market. The report also provides Porter’s five forces analysis, the acquisitions timeline of drug and gene delivery systems market companies, SWOT analysis of the market, regulatory scenario, and comparative analysis of the drug and gene delivery systems market policies.

Browse Detail Report @ https://www.researchmoz.us/drug-and-gene-delivery-systems-market-global-industry-analysis-size-share-volume-growth-trends-and-forecast-20172025-report.html

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors would help market players decide about their business strategies and plans in order to strengthen their position in the global market. Based on geography, the market has been categorized into regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the drug and gene delivery systems market.

The report also profiles major players operating in the drug and gene delivery systems market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the report are Oxford BioMedica, Pfizer, Inc., Amgen Inc., Astrazeneca plc, Bayer AG, SiBiono GeneTech Co., Shanghai Sunway Biotech Co., Ltd., Human Stem Cells Institute, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Novartis AG, and Becton, Dickinson and Company.

The drug and gene delivery systems market has been segmented as follows:

Drug and Gene Delivery Systems Market, by Delivery System

Drug Delivery Systems
- Intrauterine Implants
- Prodrug Implants
- Polymeric Drug Delivery
- Targeted Drug Delivery

Gene Delivery Systems

Viral Gene Delivery
- Adenovirus Vector
- Lentivirus Vector
- Retrovirus Vector
- Adeno-associated Virus Vector
- Sendai Virus Vector
- Herpes Simplex Virus Vector
- Others

Non-viral Gene Delivery
- Natural Organic Compounds
- Physical Methods
- Chemical Methods

Combined Hybrid System

Drug and Gene Delivery Systems Market, by Route of Administration
- Oral
- Injectable
- Inhalation
- Transdermal
- Ocular
- Nasal
- Topical

Drug and Gene Delivery Systems Market, by Application
- Infectious Diseases
- Oncology
- Ophthalmology
- Urology
- Diabetes
- CNS
- Others

Get PDF for More Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1707720

Drug and Gene Delivery Systems Market, by Geography

North America
- U.S.
- Canada

Europe
- U.K.
- Germany
- Spain
- France
- Italy
- Rest of Europe

Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of LATAM

Middle East & Africa
- GCC
- South Africa
- Israel
- Rest of MEA

Global Needle Free Drug Delivery Devices Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Researchmoz added Most up-to-date research on "Needle Free Drug Delivery Devices Market (Jet Injectors and Competing Needle-Free Technologies; Vaccine Delivery, Pain Management, Insulin Delivery, Pediatric Injections, and Other) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023" to its huge collection of research reports.

This report on the needle free drug delivery devices market analyzes the current and future scenario of the global market. Large number of chronic pain and diabetes sufferers is increasing the usage of needle free drug delivery devices. Less pain and consistency in drug delivery are the major drivers of the global needle free drug delivery devices market.

The needle free drug delivery devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global needle free drug delivery devices market.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=718469

Based on technology, the market has been segmented into jet injectors and competing needle-free technologies. The competing needle-free technologies segment has been further divided into novel needle technology, inhaler technology, and transdermal patch technology. Novel needle technology includes micro-needle and pen needle. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on application, the needle free drug delivery devices market has been segmented into five major categories: vaccine delivery, pain management, insulin delivery, pediatric injections, and others. Other applications of needle free drug delivery devices include angina, hypertension, and other medical conditions. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global needle free drug delivery devices market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global needle free drug delivery devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Zogenix, Inc., 3M Health Care, Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet, Inc.

The global needle free drug delivery devices market has been segmented as follows:

Global Needle Free Drug Delivery Devices Market Revenue, by Technology, (US$ Mn), 2013–2023
- Jet Injectors
- Competing Needle-free Technologies
- Novel Needle Technology
- Inhaler Technology
- Transdermal Patch Technology

Global Needle Free Drug Delivery Devices Market Revenue, by Application, (US$ Mn), 2013–2023

- Vaccine Delivery
- Pain Management
- Insulin Delivery
- Pediatric Injections
- Other Applications

Global Needle Free Drug Delivery Devices Market Revenue, By Geography, (US$ Mn), 2013–2023

- Overview
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=718469

Global Inhalation Systems Industry Analysis, Market Size, Share, Growth, Trends and Forecast 2013 – 2019

Researchmoz added Most up-to-date research on "Inhalation Systems Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its huge collection of research reports.

The era of development is leading to a hazardous increase in environmental pollution, which is giving birth to a number of chronic respiratory diseases such as asthma and COPD and is resulting in both physical and psychological suffering for the patients. The global market for inhalation systems is growing rapidly because of increasing respiratory problems and is expected to have a high growth rate during the period from 2012 to 2018. The United States and Europe hold the maximum market share because these are industrialized countries with more environmental pollution.

Some of the key drivers of this market are industrialization which leads to pollution and chronic respiratory problems, easy-to-use inhalation devices available in market, faster delivery, a bigger area for absorbing, cost effectiveness, and technological advancements. Some of the factors restraining the growth are difficulty in standardizing dosages for patients, and technical issues in designing inhalers. The market can be segmented on the basis of inhalation products into metered dose inhalers, dry powder inhalers, and liquid droplet inhalers and nebulizers.

Metered dose inhalers (MDI) use pressurized gas to release the dose when they are activated by the patient. MDIs constitute the largest market share among inhalation systems. Dry powder inhalers are used for treating cystic fibrosis, a life threatening lung disease. It constitutes the second largest product segment in the inhalation systems market. North America and Europe currently lead the market for inhalation systems followed by Asia-Pacific and Africa, but the market is expected to expand rapidly in Asia and Africa due to an increase in diabetic patients.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=171888

Some of the key companies in this sector are Mankind, Akela Pharma (Canada), Alkermes, AOP Orphan Pharmaceuticals, DEY L.P. (USA), Consort Medical PLC (UK), Alpharx Inc., GlaxoSmithKline Plc (UK) and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World 

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=171888

Insulin Delivery Devices Industry Key Trends, Size, Growth, Shares And Forecast Research Report 2019

Researchmoz added Most up-to-date research on "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" to its huge collection of research reports.

GBI Research’s report: Insulin Delivery Devices Market to 2019 examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- The markets of 12 key geographies are covered: US, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Annual market revenue data forecast to 2019 and company share data for 2012.
- Qualitative analysis of key trends in the insulin delivery devices market.
- Information on the competitive landscape and the leading technologies of key players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly, Becton, Dickinson and Company, Animas, Insulet, F. Hoffmann-La Roche, Abbott Laboratories.
- Information on reimbursement trends and market access for key countries.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=192953

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market.
- Design and enhance your product development, marketing, and sales strategies.
- Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines.
- Develop market-entry and market-expansion strategies.
- Identify the key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
- Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape.
- Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=192953

Worldwide Needle Free Drug Delivery Devices Market Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Researchmoz added Most up-to-date research on "Needle Free Drug Delivery Devices Market (Jet Injectors and Competing Needle-Free Technologies; Vaccine Delivery, Pain Management, Insulin Delivery, Pediatric Injections, and Other) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023" to its huge collection of research reports.

This report on the needle free drug delivery devices market analyzes the current and future scenario of the global market. Large number of chronic pain and diabetes sufferers is increasing the usage of needle free drug delivery devices. Less pain and consistency in drug delivery are the major drivers of the global needle free drug delivery devices market.

The needle free drug delivery devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global needle free drug delivery devices market.

Based on technology, the market has been segmented into jet injectors and competing needle-free technologies. The competing needle-free technologies segment has been further divided into novel needle technology, inhaler technology, and transdermal patch technology. Novel needle technology includes micro-needle and pen needle. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=718469

Based on application, the needle free drug delivery devices market has been segmented into five major categories: vaccine delivery, pain management, insulin delivery, pediatric injections, and others. Other applications of needle free drug delivery devices include angina, hypertension, and other medical conditions. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global needle free drug delivery devices market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global needle free drug delivery devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Zogenix, Inc., 3M Health Care, Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet, Inc.

The global needle free drug delivery devices market has been segmented as follows:

Global Needle Free Drug Delivery Devices Market Revenue, by Technology, (US$ Mn), 2013–2023
- Jet Injectors
- Competing Needle-free Technologies
- Novel Needle Technology
- Inhaler Technology
- Transdermal Patch Technology

Global Needle Free Drug Delivery Devices Market Revenue, by Application, (US$ Mn), 2013–2023

- Vaccine Delivery
- Pain Management
- Insulin Delivery
- Pediatric Injections
- Other Applications

Global Needle Free Drug Delivery Devices Market Revenue, By Geography, (US$ Mn), 2013–2023

- Overview
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=718469

Insulin Delivery Devices Market Trends, Size, Growth, Shares And Forecast Research Report 2019

Researchmoz added Most up-to-date research on "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" to its huge collection of research reports.

GBI Research’s report: Insulin Delivery Devices Market to 2019 examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- The markets of 12 key geographies are covered: US, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Annual market revenue data forecast to 2019 and company share data for 2012.
- Qualitative analysis of key trends in the insulin delivery devices market.
- Information on the competitive landscape and the leading technologies of key players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly, Becton, Dickinson and Company, Animas, Insulet, F. Hoffmann-La Roche, Abbott Laboratories.
- Information on reimbursement trends and market access for key countries.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=192953

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market.
- Design and enhance your product development, marketing, and sales strategies.
- Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines.
- Develop market-entry and market-expansion strategies.
- Identify the key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
- Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape.
- Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=192953